Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and young people under 18 years old who have been diagnosed with Inflammatory Bowel Disease (IBD), which includes Crohn's disease, ulcerative colitis, or IBD that has not been fully classified into a specific type
- People in this age group who are receiving treatment with one of the following medications — Infliximab, Adalimumab, Vedolizumab, or Ustekinumab — either during the initial treatment phase or the ongoing maintenance phase
Who may not be able to join:
- Children and young people who have a primary (congenital) immunodeficiency, meaning a condition present from birth where the immune system does not work properly
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +43 (0)512/504-82184
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pharmacokinetic Evaluation of Plasma Level of Biological Therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.